Progesterone SR 100 mg Capsules
Reason Labeling Not Elsewhere Classified: Misbranding.
17,898 recalls, newest first
Reason Labeling Not Elsewhere Classified: Misbranding.
Reason Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Reason Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.
Reason Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.
Reason Lack of assurance of sterility: loss of container integrity.
Reason Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
Reason CGMP Deviations; rejected product was used to manufacture final bulk lot
Reason Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Reason Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Reason Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.
Reason Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion.
Reason Microbial Contamination of Non-Sterile Product
Reason Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
Reason Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.
Reason Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Reason Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
Reason Failed Impurities/Degradation Specifications: OOS for unknown impurities.
Reason Failed Impurities/Degradation Specifications: OOS for unknown impurities.
Reason Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility
Reason Lack of Assurance of Sterility